Management of rheumatic chorea: an observational study
Arq. neuropsiquiatr
;
60(2A): 231-233, June 2002. tab
Artículo
en Inglés
| LILACS
| ID: lil-309214
RESUMO
BACKGROUND:
Rheumatic chorea (RC) has recently been linked to an antibody-mediated immune mechanism. OBJECTIVE/METHOD:
To verify if this knowledge reflected in management changes we conceived a descriptive study.RESULTS:
The medical charts of 20 children (13 females) aged 6 to 12 years (mean 8 years), diagnosed as RC from June 1996 to June 1999, were reviewed. All patients received some medical treatment. Haloperidol was the most prescribed medication (15 patients - 75 percent). Sulpiride, diazepam and valproate were also used as symptomatic treatment. Imune-modulating therapy with prednisone was prescribed for seven children. The shortest course of chorea (16 days) occurred in a patient treated with prednisone.CONCLUSION:
Prednisone has been prescribed for rheumatic chorea besides the traditional symptomatic approach. A great variety of antichoreic drugs are being employed
Texto completo:
Disponible
Índice:
LILACS (Américas)
Asunto principal:
Corea
Tipo de estudio:
Estudio observacional
/
Estudio de prevalencia
/
Factores de riesgo
Límite:
Niño
/
Femenino
/
Humanos
Idioma:
Inglés
Revista:
Arq. neuropsiquiatr
Asunto de la revista:
Neurología
/
Psiquiatria
Año:
2002
Tipo del documento:
Artículo
País de afiliación:
Brasil
Institución/País de afiliación:
Universidade Federal do Rio de Janeiro/BR
Similares
MEDLINE
...
LILACS
LIS